Prof Shabir Madhi gives update on COVID-19 vaccine trials in SA

The University of the Witwatersrand has been involved in a couple of COVID-19 vaccine trials. One of them is Oxford University’s AstraZeneca vaccine candidate, which announced its 70 per cent efficacy on average. Joining CNBC Africa to give an update on those vaccine trials is Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand.

Wed, 25 Nov 2020 10:51:51 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.